BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 22027259)

  • 1. IMRT for sinonasal tumors minimizes severe late ocular toxicity and preserves disease control and survival.
    Duprez F; Madani I; Morbée L; Bonte K; Deron P; Domján V; Boterberg T; De Gersem W; De Neve W
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):252-9. PubMed ID: 22027259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensity-modulated radiotherapy for sinonasal tumors: Ghent University Hospital update.
    Madani I; Bonte K; Vakaet L; Boterberg T; De Neve W
    Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):424-32. PubMed ID: 18755554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensity-modulated radiation therapy for malignancies of the nasal cavity and paranasal sinuses.
    Daly ME; Chen AM; Bucci MK; El-Sayed I; Xia P; Kaplan MJ; Eisele DW
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):151-7. PubMed ID: 17189068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postoperative intensity-modulated radiotherapy in sinonasal carcinoma: clinical results in 39 patients.
    Duthoy W; Boterberg T; Claus F; Ost P; Vakaet L; Bral S; Duprez F; Van Landuyt M; Vermeersch H; De Neve W
    Cancer; 2005 Jul; 104(1):71-82. PubMed ID: 15915466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensity-modulated radiotherapy for sinonasal cancer: improved outcome compared to conventional radiotherapy.
    Dirix P; Vanstraelen B; Jorissen M; Vander Poorten V; Nuyts S
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):998-1004. PubMed ID: 20338694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensity-modulated radiotherapy for tumors of the nasal cavity and paranasal sinuses: clinical outcomes and patterns of failure.
    Wiegner EA; Daly ME; Murphy JD; Abelson J; Chapman CH; Chung M; Yu Y; Colevas AD; Kaplan MJ; Fischbein N; Le QT; Chang DT
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):243-51. PubMed ID: 22019239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensity modulated radiation therapy (IMRT) for sinonasal tumors: a single center long-term clinical analysis.
    Askoxylakis V; Hegenbarth P; Timke C; Saleh-Ebrahimi L; Debus J; Röder F; Huber PE
    Radiat Oncol; 2016 Feb; 11():17. PubMed ID: 26847089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salivary gland tumors treated with adjuvant intensity-modulated radiotherapy with or without concurrent chemotherapy.
    Schoenfeld JD; Sher DJ; Norris CM; Haddad RI; Posner MR; Balboni TA; Tishler RB
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):308-14. PubMed ID: 21075557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carcinomas of the paranasal sinuses and nasal cavity treated with radiotherapy at a single institution over five decades: are we making improvement?
    Chen AM; Daly ME; Bucci MK; Xia P; Akazawa C; Quivey JM; Weinberg V; Garcia J; Lee NY; Kaplan MJ; El-Sayed I; Eisele DW; Fu KK; Phillips TL
    Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):141-7. PubMed ID: 17459609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensity modulated radiotherapy (IMRT) in patients with carcinomas of the paranasal sinuses: clinical benefit for complex shaped target volumes.
    Combs SE; Konkel S; Schulz-Ertner D; Münter MW; Debus J; Huber PE; Thilmann C
    Radiat Oncol; 2006 Jul; 1():23. PubMed ID: 16859556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late toxicity after intensity-modulated radiation therapy for localized prostate cancer: an exploration of dose-volume histogram parameters to limit genitourinary and gastrointestinal toxicity.
    Pederson AW; Fricano J; Correa D; Pelizzari CA; Liauw SL
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):235-41. PubMed ID: 21163587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
    Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR
    Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of nasal cavity and paranasal sinus cancer with modern radiotherapy techniques in the postoperative setting--the MSKCC experience.
    Hoppe BS; Stegman LD; Zelefsky MJ; Rosenzweig KE; Wolden SL; Patel SG; Shah JP; Kraus DH; Lee NY
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):691-702. PubMed ID: 17161557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
    Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Definitive Carbon-Ion Radiation Therapy for Locally Advanced Sinonasal Malignant Tumors: Subgroup Analysis of a Multicenter Study by the Japan Carbon-Ion Radiation Oncology Study Group (J-CROS).
    Koto M; Demizu Y; Saitoh JI; Suefuji H; Tsuji H; Okimoto T; Ohno T; Shioyama Y; Ikawa H; Nemoto K; Nakano T; Kamada T;
    Int J Radiat Oncol Biol Phys; 2018 Oct; 102(2):353-361. PubMed ID: 30191869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative toxicity and dosimetric profile of whole-pelvis versus prostate bed-only intensity-modulated radiation therapy after prostatectomy.
    Deville C; Vapiwala N; Hwang WT; Lin H; Ad VB; Tochner Z; Both S
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1389-96. PubMed ID: 21664069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postoperative intensity-modulated radiation therapy for cancers of the paranasal sinuses, nasal cavity, and lacrimal glands: technique, early outcomes, and toxicity.
    Hoppe BS; Wolden SL; Zelefsky MJ; Mechalakos JG; Shah JP; Kraus DH; Lee N
    Head Neck; 2008 Jul; 30(7):925-32. PubMed ID: 18302261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma.
    Lu TX; Mai WY; Teh BS; Zhao C; Han F; Huang Y; Deng XW; Lu LX; Huang SM; Zeng ZF; Lin CG; Lu HH; Chiu JK; Carpenter LS; Grant WH; Woo SY; Cui NJ; Butler EB
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):682-7. PubMed ID: 14967420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unresectable carcinoma of the paranasal sinuses: outcomes and toxicities.
    Hoppe BS; Nelson CJ; Gomez DR; Stegman LD; Wu AJ; Wolden SL; Pfister DG; Zelefsky MJ; Shah JP; Kraus DH; Lee NY
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):763-9. PubMed ID: 18395361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience.
    de Arruda FF; Puri DR; Zhung J; Narayana A; Wolden S; Hunt M; Stambuk H; Pfister D; Kraus D; Shaha A; Shah J; Lee NY
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):363-73. PubMed ID: 15925451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.